UniProtKB/Swiss-Prot Q16281: Variant p.Thr153Met

Cyclic nucleotide-gated channel alpha-3
Gene: CNGA3
Feedback?

Variant information Variant position:

153 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Threonine (T) to Methionine (M) at position 153 (T153M, p.Thr153Met). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (T) to medium size and hydrophobic (M) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs34314205 [ dbSNP | Ensembl ]

Sequence information Variant position:

153 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

694 The length of the canonical sequence.
Location on the sequence:

AWPLAKCNTNTSNNTEEEKK T KKKDAIVVDPSSNLYYRWLT The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         AWPLAKCNTNTSNNTEEEKKT-------------------KKKDAIVVDPSSNLYYRWLT

Mouse                         ----------------------------------------R

Rat                           ----------------------------------------R

Bovine                        AWPLARNNTNTCNNSEKDDKAKKEEKEKKEEKKENPKKEEK

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 694	Cyclic nucleotide-gated channel alpha-3
Topological domain	1 – 170	Cytoplasmic

Literature citations
Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel.
Kohl S.; Marx T.; Giddings I.; Jaegle H.; Jacobson S.G.; Apfelstedt-Sylla E.; Zrenner E.; Sharpe L.T.; Wissinger B.;
Nat. Genet. 19:257-259(1998)
Cited for: VARIANTS ACHM2 LEU-163; GLN-283; TRP-283; ARG-291; TRP-410; MET-529; LEU-547 AND ARG-557; VARIANT MET-153; Cone cGMP-gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases.
Nishiguchi K.M.; Sandberg M.A.; Gorji N.; Berson E.L.; Dryja T.P.;
Hum. Mutat. 25:248-258(2005)
Cited for: VARIANTS ACHM2 TRP-223; SER-249; ASP-263; CYS-277; PRO-341; PRO-401; TRP-410; CYS-427; TRP-436; MET-529; MET-565 AND LYS-590; VARIANTS LEU-48 AND MET-153;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.